Olivia Buonarati Asfaha

Chief Operating Officer at Neurexis Therapeutics

Olivia Buonarati Asfaha has been working in the field of research and development since 2018. Olivia began their career as a Postdoctoral Research Fellow at the University of Colorado Denver. In 2021, they joined Neurexis Therapeutics as the Director of Research and Development and Program Manager. In 2022, they moved to Solaris Vaccines as a Program Manager.

Olivia Buonarati Asfaha earned their Bachelor of Science in Environmental Science from Seattle University between 2008 and 2012. Olivia then went on to earn their Doctor of Philosophy in Pharmacology and Toxicology from the University of California, Davis between 2012 and 2018. In June 2022, Olivia obtained a DFARS7012 / 800-171 / CMMC TRAINING certification from Totem Technologies. Olivia also obtained a Google Program Management Certificate from Coursera in February 2022.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Neurexis Therapeutics

Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.


Industries

Employees

1-10

Links